BSE filing, NSE: BOMBCYC. Summary written from the filing by ALFA Finder's alert engine.
Bombay Cycle & Motor Agency Ltd: key numbers
- Share price
- ₹1,520.00
- Market cap
- ₹60.80 Cr
- Revenue (annual)
- ₹12.42 Cr
- Net profit (annual)
- ₹2.44 Cr
- P/E (TTM)
- 27.8×Sector 43.7×
- Promoter holding
- 72.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bombay Cycle & Motor Agency Ltd
All →Bombay Cycle & Motor Agency Annual General Meeting
Bombay Cycle & Motor Agency Ltd. held its 107th Annual General Meeting on August 07, 2026. Shareholders considered business items including financial statements and dividend declaration.
Bombay Cycle & Motor Agency Q1 FY27 Results: Net Profit ₹1.4 Cr, Down 12.5% YoY
Bombay Cycle & Motor Agency Ltd reported revenue from operations of ₹2.8 Cr (+12.0% YoY) and net profit of ₹1.4 Cr (-12.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.4 Cr · -12.5% YoY
Bombay Cycle & Motor Agency Board Meeting Date
Bombay Cycle & Motor Agency Ltd has scheduled a board meeting for August 07, 2026, to consider and approve the financial results for the quarter ended June 30, 2026.
Bombay Cycle & Motor Agency Annual General Meeting
Bombay Cycle & Motor Agency Limited scheduled its 107th AGM for August 7, 2026. Key agendas include adopting FY26 financial results and declaring a final dividend.
Bombay Cycle & Motor Agency Annual Report
Bombay Cycle & Motor Agency Ltd submitted its FY 2025-26 Annual Report. The 107th Annual General Meeting is scheduled for August 07, 2026.
Bombay Cycle & Motor Agency Annual General Meeting
Bombay Cycle & Motor Agency Ltd will hold its AGM on 7 Aug 2026. A dividend of Rs 5 per share is proposed, with book closure 25‑30 July.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.